Expert commentary from CCO on nursing management of immune-related adverse events in patients with cancer receiving checkpoint inhibitors.
Review critical updates in non-small-cell lung cancer treatment that may improve the care of patients with advanced NSCLC in this archived presentation of a meeting in the VHA system.
ZUMA-1 update: extended 2-year follow-up data of axicabtagene ciloleucel in patients with refractory large B-cell lymphoma from CCO coverage of ASH 2018.
CME-certified Webcast from CCO featuring 3 expert faculty providing recommendations for PARP inhibitors in BRCA-positive pancreatic cancer.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.